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Abstract.  Cytochrome P450b  is an integral membrane 
protein of the rat hepatocyte endoplasmic reticulum 
(ER) which is cotranslationally inserted into the mem- 
brane but remains largely exposed on its cytoplasmic 
surface. The extreme hydrophobicity of the amino- 
terminal portion of P450b  suggests  that it not only 
serves to initiate the cotranslational insertion of the 
nascent polypeptide but that it also halts translocation 
of downstream portions into the lumen of the ER and 
anchors the mature protein in the membrane. In an in 
vitro system, we studied the cotranslational insertion 
into ER membranes of the normal P450b  polypeptide 
and of various deletion variants and chimeric proteins 
that contain portions of P450b  linked to segments of 
pregrowth hormone or bovine opsin. The results 
directly established that the amino-terminal 20 
residues of P450b  function as a combined inser- 
tion-halt-transfer signal. Evidence was also obtained 
that suggests  that during the early stages of insertion, 
this signal enters the membrane in a loop configura- 
tion since, when the amino-terminal hydrophobic seg- 
ment was placed immediately before a signal peptide 
cleavage  site,  cleavage by the luminally located signal 
peptidase took place. After entering the membrane, 
the P450b  signal, however,  appeared to be capable of 
reorienting within the membrane since a bovine opsin 
peptide segment linked to the amino terminus of the 
signal became translocated into the microsomal lumen. 
It was also found that, in addition to the amino- 
terminal combined insertion-halt-transfer signal, only 
one other segment within the P450b  polypeptide, lo- 
cated between residues  167 and  185, could serve as a 
halt-transfer signal and membrane-anchoring domain. 
This segment was shown to prevent translocation of 
downstream sequences when the amino-terminal com- 
bined signal was replaced by the conventional cleav- 
able insertion signal of a secretory protein. 
T 
HE  endoplasmic  reticulum  (ER) ~ is  a  membrane- 
bound  organelle  richly  endowed  with  a  variety  of 
enzymatic systems that operate on cytoplasmic sub- 
strates or on molecules  segregated in its lumen.  Some of 
these  systems  carry  out  general  biosynthetic  functions 
whereas others participate in metabolic reactions that may be 
characteristic of specific cell types. Several different mecha- 
nisms ensure that proteins incorporated into the ER acquire 
the disposition, with.respect to the membrane, that is neces- 
sary for their function. Those polypeptides that reside in the 
ER lumen or are peripherally attached to the luminal surface 
of the membrane,  such as the hepatocyte microsomal ester- 
ases (36), the disulfide exchange enzyme (15), and a recently 
described protein that binds incompletely assembled secre- 
tory polypeptides (7, 40), must use the same mechanism that 
is used to segregate newly synthesized secretory proteins and 
lysosomal hydrolases into the lumen. These nascent chains 
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I.  Abbreviation used in this paper:  ER, endoplasmic reticulum. 
contain amino-terminal transient signal sequences that deter- 
mine their cotranslational  insertion  into the membranes of 
the rough ER and mediate their complete translocation into 
the lumen of the organelle. 
Those ER proteins,  such as the ribophorins  (24, 51) and 
UDP  glucuronyl-transferase  (35),  that have single  mem- 
brane-spanning segments and large glycosylated amino-ter- 
minal domains free in the lumen of the ER are topologically 
similar to a class of well-studied plasma membrane glyco- 
proteins (type I proteins), which includes the G and HA viral 
envelope glycoproteins and the low density lipoprotein and 
epidermal growth factor receptors (21, 22, 48, 53, 64). These 
proteins are thought to acquire their transmembrane disposi- 
tion during their synthesis as a result of the action of two 
different types of signals that are present  within the same 
polypeptide chain (5, 53): a cleavable amino-terminal inser- 
tion signal which is equivalent to that in secretory proteins, 
and  a  halt-transfer  signal which  interrupts  cotranslational 
translocation and contains a hydrophobic segment that serves 
to permanently anchor the mature protein in the membrane. 
The relative lengths of the luminal and cytoplasmic domains 
of these proteins are determined by the location of the halt- 
transfer signal within the polypeptide. 
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not glycosylated and are almost completely exposed on the 
cytoplasmic surface of the ER membrane (see reference 30). 
Some  polypeptides  of this  type,  like  cytochrome b5  and 
NADH-cytochrome b5  reductase, are  synthesized on free 
polyribosomes and are inserted in the membranes only after 
they are discharged into the cytosol (8, 44, 47). Others, such 
as NADPH-cytochrome P450 reductase, are synthesized on 
membrane-bound ribosomes but do not undergo extensive 
translocation across the membrane (4, 44). The P450 reduc- 
tase, for example, is anchored in the membrane solely by a 
short hydrophobic segment that is located near the amino- 
terminus (4, 46) and is likely to serve both as an uncleaved 
insertion signal and as a membrane-anchoring domain. The 
fact  that  the  regions  of the  polypeptide  that  follow  the 
membrane-embedded segment are not translocated across 
the ER membrane suggests that this segment also serves as 
a halt-transfer signal which, after insertion into the mem- 
brane, interrupts translocation. In this regard, the permanent 
insertion-signal membrane-anchoring domain of such pro- 
teins differs fundamentally from the permanent insertion- 
signal membrane-anchoring domains identified in plasma 
membrane glycoproteins that cross the membrane only once 
but have large luminally exposed carboxy-terminal portions 
(type II proteins), such as the influenza neuroaminidase (6), 
the sucrase isomaltase (26), and the asialoglycoprotein (57) 
and transferrin receptors (56).  In these cases, the insertion 
signals, although remaining membrane associated, are able 
to mediate the translocation of later portions of the polypep- 
tides across the membrane. 
Like its reductase, hepatic cytochrome P450,  the mixed 
function oxidase responsible for the metabolism of a wide 
variety of endogenous and exogenous substrates, is also syn- 
thesized on membrane-bound ribosomes and does not un- 
dergo cleavage of a signal sequence during its insertion into 
the membrane (3, 45). Although it is now clear that there are 
at least a dozen distinct species of cytochrome P450 in rat 
liver (1), most studies on the biosynthesis and membrane dis- 
position of these polypeptides (3, 13, 34, 60) have been car- 
ried out with two closely related ('~97%  sequence iden- 
tity) phenobarbital-inducible forms, P450b and P450e,  now 
designated P450IIB1 and P450IIB2  (42).  The use of macro- 
molecular probes such as proteases (10, 43), antibodies (13, 
52, 60), and enzymatic labeling reagents (50, 63) has shown 
that large portions of these P450 polypeptides are exposed 
on the cytoplasmic surface of the ER membrane, although 
it has not been possible to recover after proteolytic treatment 
of intact microsomal vesicles sizable solubilized fragments 
of these molecules.  These findings, together with the ex- 
tremely hydrophobic character of the amino-terminal seg- 
ment of P450b (Fig. 2), have suggested (3) that this segment 
also serves as a combined insertion-halt-transfer signal that 
determines the cytoplasmic exposure of the later portions of 
the polypeptide. 
In  this work we  have analyzed the  role of the  amino- 
terminal portion of cytochrome P450b in determining the in- 
corporation of this polypeptide into the ER membrane and 
its disposition with respect to the phospholipid bilayer.  The 
results demonstrate that the amino-terminal 20 residues of 
P450 display both insertion and halt-transfer functions and 
suggest that this portion of the polypeptide first enters the 
membrane in a  loop configuration and soon thereafter re- 
orients so that the amino terminus is transferred from the cy- 
toplasmic to the luminal side of the membrane. It is proposed 
that this reorientation leads to the halt in translocation. 
Materials and Methods 
Reagents 
SP6  RNA  polymerase,  RNase  inhibitor  (RNasin),  and  the pSP64  and 
pSP65 vector plasmids were purchased from Promega Biotec (Madison, 
WI) and other polymerases, restriction endonucleases, and mung bean exo- 
nuclease from New England Biolabs (Beverly, MA) and Bethesda Research 
Laboratories (Gaithersburg, MD). 7mGpppG was purchased from Pharma- 
cia Fine Chemicals Inc. (Piscataway,  N J), and other nncleotides were pur- 
chased from Boehringer Mannheim Biochemicals (Indianapolis, IN). All 
radiolabeled compounds were purchased from New England Nuclear (Bos- 
ton, MA). 
OUgonucleotides 
Three  synthetic  double-stranded  oligonucleotides  were  used  to  insert 
specific coding sequences into gene constructs or to link two pieces of DNA. 
Each was prepared by annealing as described below.  ~  complementary 
single-stranded oligonucleotides were synthesized by the phosphoramidite 
method with an Applied Biosystems Inc.  (Foster City, CA) model 380A 
DNA synthesizer. After the deblocking reaction in presence of NH4OH, 
the oligonucleotides were purified by gel filtration through Sephadex G50, 
mixed, and annealed by boiling for 5 min in 0.5 M NaC1, 6.5 mM Tris-HCI, 
pH 7.5, 8 mM MgCI2,  1 mM dithiothreitol, followed by rapid cooling to 
65°C, and then slow cooling to room temperature. After annealing, the solu- 
tion was desalted by gel filtration on a  Sephadex G50 column, and the 
double-stranded product was purified by electrophoresis on a  10%  poly- 
acrylamide gel, followed by electroelution. 
Plasmid Construction 
All the cDNAs were cloned into the plasmid vector pSP64 downstream 
from the SP6 bacteriophage promoter. The construction from two overlap- 
ping cDNA clones and a segment of a genomic clone of pSP450,  a recom- 
binant plasmid that contains the complete coding region of P450b cDNA 
in the plasmid vector pSP64,  is described by Dohmer, J.,  S.  Dogra,  T. 
Friedberg, S. Monier, M. Adesnik, H. Glatt, and E  Oeschi (manuscript sub- 
mitted for publication). The procedures used in constructing pSP450(s-), 
pSpGHL_39P45044_491, pSP4501_48, pGH3s-216, and  pSP4501_20pGHzI_2)6 are 
described in Fig. 1. The construction of the other plasmids used is described 
below. A list of the hybrid and modified polypeptides encoded in all these 
genes and relevant portions of their amino acid sequences are  shown in 
Fig. 2. 
Truncated Derivatives of pSpGHmgP450~4_491 
Plasmids encoding a series of hybrid polypeptides similar to that encoded 
by  pSpGH~_39P45044_491 but  lacking  carboxy-terminal portions of P450, 
were obtained by digestion of that plasmid with the appropriate restriction 
enzyme(s) and religation in the same vector, the termination codon being 
provided by the vector sequence. The P450 portions encoded in these deriv- 
atives terminated at amino acid residues 167, 246,  271, or 425 as a result 
of cleavages at the unique Bam HI, Bal I, Fsp I, and Hind llI sites, respec- 
tively. For the first construct, the original plasmid was simply cut with Barn 
HI to remove the 3' portion of the P450 cDNA and religated. The resulting 
plasmid  (pSpGHI 39P45044-167) encodes  a  polypeptide  that  contains  6 
(R A S S N S) additional COOH-terminal amino acids. The second plas- 
mid (pSpGH~_39P45044 246) was obtained by digestion of the parental plas- 
mid with Bal I and Sma I and religation. The encoded polypeptide contains 
33  additional  amino  acids  at  its  COOH  terminus.  The  third  plasmid 
(pSpGH] 39P45044 27~) was obtained by cloning the Hind III-Fsp I fragment 
of the parental plasmid back into pSP64 cleaved with Hind III and Hinc II. 
The encoded polypeptide contained one extra amino acid, leucine, at its 
COOH terminus. The plasmid pSpGHl_39P45044 425 was obtained by clon- 
ing the Hind Ill fragment of the parental plasmid into pSP64.  Six amino 
acids (W A A G R L) were added at the COOH terminus of the encoded 
polypeptide. 
p SpG  H1-  39P4  5 0  aa~-2o  3) 
This plasmid encodes a  hybrid polypeptide similar to pGHt 39P45044 491 
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of P450 was deleted. To effect this deletion, an Hpa II P450 cDNA fragment 
(bp 639 to 1035) was isolated from pSpGH~_39P45044_491  and, after its pro- 
truding ends were filled in with the Klenow fragment of DNA polymerase, 
it  was  ligated to pSpGH~_39P45044~91 from which  the  Bam HI  P450 3' 
cDNA fragment had been removed and the ends had been made blunt with 
mung bean nuclease. The Hind III-Fsp I fragment of this intermediate, car- 
rying the required deletion, was rejoined to the 3' end of the P450 cDNA 
in a three-way ligation with the Fsp 1-Bam HI fragment of pSP4503 (shown 
in Fig.  1 A) and the vector pSP64  cleaved with Hind III and pSP4503, 
Bam HI. 
p SpG  H i-  3~4  5 0 zo~  ~91 
This plasmid encodes a hybrid polypeptide in which the first 39 residues 
of pregrowth hormone are linked to the carboxy-terminal 288 residues of 
Figure 1.  (A) Construction of pSP450(s-). This plasmid encodes a 
P450b polypeptide from which amino acids 2--43 were deleted. The 
manipulations involved in this construction were designed to fuse 
the filled-in Nco I site which contains the initiation codon with the 
Pst I site, without altering the reading frame. Nucleotides linking 
the two sites were derived from the multiple cloning site of pSP65. 
This resulted in one extra amino acid (Asp) being added at position 
2, which was followed directly by Leu 44 of P450. (B) Construction 
of pSpGHt-39P45044~9t.  This plasmid encodes a  chimeric protein 
in which the first 39 amino acids of rat pregrowth hormone were 
linked to residues 44--491  (COOH terminus) of P450 via a  short 
extraneous peptide (DSRVD) encoded by a portion of the multiple 
cloning site  in  the  vector  pSP65.  The  first  ll7-bp  fragment  of 
pregrowth hormone cDNA, coding for the signal peptide plus 13 
amino acids of the mature growth hormone, was linked to a 3' por- 
tion of the P450 cDNA located downstream from the Pst I site (con- 
tained in plasmid pSP450y, shown in A) by a small DNA segment 
derived from the multiple cloning sites of pSP64 and pSP65.  (C) 
The  plasmid  pSP4501~spGH38-2t6 encodes  a  hybrid polypeptide 
consisting of the  amino-terminal 48  residues  of P450  followed 
by the growth hormone sequence, beginning at residue 38 of pre- 
growth hormone (i.e.,  residue  12 of the mature protein) and ex- 
tending to its COOH-terminal end. In this construction, the 5' Nco 
I-Pst I fragment of the P450 cDNA was linked to a 3' fragment of 
the rat growth hormone cDNA beginning at its Hgi AI site. This 
was achieved using a double-stranded oligonucleotide adaptor (21- 
mer) that encodes three amino acids of rat pregrowth hormone (Asn 
38 to Val 40) and two amino acids of P450 (Leu 46 and Arg 48) 
but introduces an alanine residue in place of an aspartic acid at posi- 
tion 47 of P450 to create a convenient  restriction site (Bal I) useful in 
subsequent cloning procedures.  The plasmid pSP4501_2opGH39-216 
encodes a hybrid polypeptide that contains the first 20 amino acids 
of P450 linked to growth hormone beginning at residue 39 of the 
pregrowth hormone sequence; i.e., residue 13 of the mature pro- 
tein. In this construction, the Nco I site of P450 was linked to the 
Hgi AI site via a synthetic adaptor that restores the first 20 codons 
of P450 (Met 1 to Va120) and residues 39 and 40 (Ala 39 Val 40) of 
rat pregrowth hormone. (D) Construction of pSP450,-20pGH2~-216. 
This plasmid encodes a hybrid polypeptide consisting of the first 
20 amino acids of P450 linked to residue 21 of the pregrowth hor- 
mone signal. The polypeptide contains the signal peptidase cleav- 
age  site (after residue 26)  in pregrowth hormone and the entire 
growth hormone sequence. First, an intermediate, pSP450t_2o-CS- 
P45044-t67 was constructed that encodes the first 20 amino acids of 
P450, an artificial signal peptidase cleavage site (DAGAL) designed 
according to the rules of von Heijne (61), four extraneous residues 
(SRVD) encoded by the vector sequence, and residues 44-167 of 
P450.  The synthetic adaptor (Dde I/Xba I double-stranded oligo- 
mer) encoding the cleavage site contained a Hinc II site at the codon 
for Val 20 of P450. This permitted direct linkage of this codon to 
codon 21 of the pregrowth hormone cDNA via the Hae III site in 
this DNA. 
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pGH: 
20 
EPSI  LLLLALLVGFLLLLVRGHPKSRGNr  ppGPR 
40  50  161 
PLPLLGNLLQLDRGG  ....  QGAPLDPTFLFQCITANI 
190  491 
I  CS  I  V F G E R F DY....Q  I  CFS  E R 
MAADSQTPHLLTFSLLCLLHPQEAGA~LPAHPLSSL 
1  20  30 
FANAVLRAQHLHQL  .....  ESSCAF 
40  216 
44  60  491 
P450(S-):  DLQLDRGGLLNSFMQLRE  .........  QICFSAR 
44  491 
pGHI-39P45044_491:  H,..A D S R V D L Q L D R,...Q  I  C F S A R 
I  39 
44  167 
pGH1-39P45044_167:  H.,.A D S R V D L Q L D R .,.  L E P R A S S N S 
1  39 
pGH]-39P45044-246: 
44  246 
M...A D S R V D LQ D R...Y  I  GGV L  E FV  I  M V I  A V S CVK 
1  39 
LLSAHNSTEHTSRKHKV 
44  271 
PGHI-39P45044_271:  H...A D S R V O L Q L O R ...  L  L R L 
]  39 
44  425 
pGH-j.~P45044_425:  M...A D S R V O L Q L D R ...S  E A H A A G R L 
1  3g 
~  4Q  1651204  491 
pGH1-39  P450 166-203:  M..,A D S R V O  L D R..,L  R T F S...Q  I  C F S A R 
1  39 
204  491 
pGHl_3gP450204_491:  M...A O S V S R T F S L,..Q  I  C F S A R 
I  39 
1  46  48 
P450]_48PGH3B_216:  N...L 8  R N A V L R..,C A F 
38  216 
1  ZO 
P4SO  _~pGH39_216:  N...V A V L R A Q H L H Q L A A D T Y K E...C A F 
39  216 
I  20 
P4501_20pGH21_216:  H...V P O E A G A L P A H P L S S L  F A N A V L  R....C A F 
21  26  Z16 
OPS  1-34P450 I-_~L,9~:  MNGTEGPNFYVPFSNKTGVVRSPF  EAPQYYLA 
1  20 
1  491 
EPCH...QICFSAR 
34 
•  ,  .1 
P450(GS):  H A A N I  S  ,..Q I  C F S A R 
/ 
120  ,~e  ~4QL  167 
P450]_20-CS-P45044_167:  N...V 0 A G  L S R V O  D R G G L  L D S....L  E P R A 
SNS 
Figure 2. Amino acid sequence of natural, mutated, and chimeric 
polypeptides used in membrane-insertion studies. The single letter 
amino acid abbreviations are used. Numbers over residues indicate 
their position within rat cytochrome P450b (20, 65). Numbers be- 
low residues correspond to position within rat pregrowth hormone 
or bovine opsin (43).  Residues that are not present in the natural 
polypeptides but are encoded by nucleotide sequences introduced 
by genetic manipulations are underlined. Asterisks, potential glyco- 
sylation sites. Arrows, potential  cleavage  sites for the signal pep- 
tidase. 
P450 via a short extraneous peptide (DSRV). For its construction, the same 
blunted Hpa II fragment of P450 cDNA (bp 639 to 1035) used in the con- 
struction of pSpGHI-39P450Atle6_2o3) was ligated to the plasmid pSpGH~_39- 
P45044-491 which was  linearized  with  Hinc  II,  an  enzyme that  cleaves 
within the short pSP65-derived segment that is  interposed between the 
growth hormone and P450 cDNA sequences. This intermediate contains 
duplicate copies of the Hpa II fragment, separated by a segment of the P450 
cDNA that extends from its Pst I site up to the Hpa II site at nucleotide 639. 
The portion of the insert in this plasmid between the Fsp I site within the 
5' Hpa II fragment and the Fsp I site within the 3' Hpa II fragment was re- 
moved by cleavage with Fsp I and religation. This reconstructs a continuous 
natural P450 cDNA sequence extending from the Hpa II site at nt 635 to 
the 3' end. 
pSOPSl_3d:~450~_491 
This plasmid encodes a protein containing the amino-terminal 34 residues 
of bovine opsin linked to the entire P450 polypeptide sequence. A single 
extraneous amino acid (cysteine) is inserted between the two sequences. For 
its construction, an Sph I-Nco I 5' fragment was removed from pSPOPS, 
a plasmid that contains the opsin cDNA inserted into the Sac I site of PSP65 
(19) and is cloned between the corresponding sites of pSP450.  In pSP450 
the Nco I site is at the initiation codon and in both plasmids the common 
Sph I site is located a short distance upstream from the SP6 promoter. The 
resulting plasmid contains an out-of-frame fusion at the Nco I site. To cor- 
rect the reading frame, the plasmid was cleaved with Nco I, treated with 
Klenow DNA  polymerase, and  religated.  This  process inserts a  codon 
(TGC) for cysteine between the opsin and P450 coding segments. 
pSV2-derived Plasmids 
pSVPtSO. This plasmid contains a full-length P450 eDNA whose transcrip- 
tion is controlled by the SV40  early promoter.  It was obtained by a  tri- 
molecular ligation involving the pSV2 vector (41) cleaved with Hind III and 
Barn HI, and the Hind III-Fsp I and Fsp I-Barn HI fragments of pSP450. 
The Fsp I-Barn HI fragment restores the SV40 polyadenylation signal which 
is removed in the cleavage of pSV2. It was shown (Dohmer, J., S. Dogra, 
T. Friedberg, S. Monier, M. Adesnik, H. Glatt, and E  Oesch; manuscript 
submitted for publication) that Chinese hamster fibroblasts permanently 
transformed with pSVP450 acquire the capacity to carry out the O-dealkyla- 
tion of 7-pentoxyresorufin, a catalytic activity characteristic of P450b. 
pSVlatSO(s-). This plasmid encodes a  P450 polypeptide from which 
residues 2-43  containing the putative insertion-halt-transfer signal were 
deleted.  For its construction, the Hind III fragment of pSP450(s-)  was 
cloned into pSV450 after removal of the Hind III eDNA fragment and treat- 
ment with bacterial alkaline phosphatase. 
Transient Expression 
and Immunofluorescence Staining 
HeLa cells were transfected with pSV450 and pSV450(s-) and examined 
by inununofluorescence as previously described (49). About 50 gg of DNA 
purified by CsCI gradient centrifugation was used to transfect a confluent 
culture in a T75 flask. Cells were examined by immunofluorescence  3 d after 
transfection using affinity-purified polyclonal antibody to rat P450b (3). 
CeU-free Transcription and Translation 
Plasmid DNAs were prepared by the alkaline lysis procedure (33).  The 
DNA preparations were treated with 20 pg/ml of RNase A for 1 h at 37°C, 
extracted  four times with  phenol-chloroform, ethanol  precipitated,  and 
desalted by several passages through a Sephadex GS0 column. About 2 pg 
of nonlinearized plasmid DNA was used in a  10-pl transcription reaction 
(31). Before addition of the ribonucleoside triphosphates, the synthetic cap 
dinucleotide mGpppG was added to 1 mM and the mixture was incubated 
for 10 min. The ribonucleotides were then added and incubation was con- 
tinued for 60 min. For translation (51), one tenth of the transcription mix- 
ture, containing ,'~200 ng of the RNA transcript, was used to program 25 
pl of a  wheat germ translation mixture which, when required, was sup- 
plemented with dog pancreas microsomal membranes. It should be noted 
that the optimal potassium ion concentration for membrane insertion and 
translocation was lower than that for translation and that it varied between 
60 and 80 mM with different batches of wheat germ extract and microsomal 
membranes. 
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The extent of insertion or translocation of polypeptides across the mem- 
branes was assessed by their resistance to proteolytic digestion effected by 
a  3-h incubation on ice with a  mixture of trypsin and chymotrypsin (0.1 
mg/ml each). The protease inhibitor trasylol was added (to 1,000 U/ml) be- 
fore addition of the buffer for gel electrophoresis. 
To determine whether polypeptides were membrane associated, aliquots 
of the translation mixture were also fractionated by flotation on a sucrose 
gradient in the presence of a high salt concentration. The samples (10 ~tl), 
adjusted to 0.6 M NaC1 and 20 mM EDTA, pH 7.5, were incubated for 30 
min on ice, mixed with 200 ~tl of 2.1 M sucrose, 50 mM triethanolamine, 
pH 7.5, 0.5 M NaCI in a 0.8-ml centrifuge tube and overlaid with 200 Ixl 
of 1.3 M sucrose followed by 200 ~tl of 0.5 M sucrose, both containing 50 
mM triethanolamine and 0.5 M NaCl. After centrifugation for 2 h at 45,000 
rpm in an SW56  rotor, the membrane fraction was recovered at the 0.5- 
1.3-M  interface and collected separately from soluble components in the 
2.1-M sucrose fraction. Both fractions were then precipitated with 10 % cold 
TCA and analyzed by SDS-PAGE. The association of the polypeptides with 
the membrane was also assessed by their resistance to extraction in media 
of alkaline pH.  To this effect, aliquots (15-~tl) of the translation reaction 
were mixed in SW56 polyallomer tubes (Beckman Instruments, Inc., Fuller- 
ton, CA) with 4 ml of 0.1 M Na2CO3, pH 11.5, and incubated for 30 min 
on ice before centrifugation at 45,000  rpm for 2 h. The membrane and su- 
pernatant  fractions were TCA  precipitated and analyzed by  SDS-PAGE 
(12-15 %) and autoradiography. 
The presence of carbohydrate residues in translation products was as- 
sessed by the effect of endoglycosidase H on their electrophoretic mobility. 
After boiling the sample (20 ~tl) in 1% SDS, 200 ~tl of 50 mM citrate, pH 
5.5, and 0.05 U of endoglycosidase H were added and the samples were in- 
cubated at 37°C overnight before precipitation with 10 % cold TCA and anal- 
ysis by gel electrophoresis. 
Results 
The Amino-Terminal 43-Amino Acid Segment 
of Cytochrome P450 Is Necessary  for the 
Cotranslational Insertion of  the Protein into 
Microsomal Membranes 
Previous work (3) using in vitro translation systems and nat- 
ural mRNA from rat liver has shown that P450 is synthesized 
in membrane-bound ribosomes and that, although its incor- 
poration into the ER membrane takes place without cleavage 
of a signal sequence (3), it involves the participation of the 
signal recognition particle (54). Although these studies indi- 
cated that nascent P450 contains a functional signal sequence 
that mediates its cotranslational insertion into the ER mem- 
brane, the location of the signal within the polypeptide was 
not directly established.  The hydrophobicity of the amino- 
terminal portion of the protein (Fig. 2), however, strongly 
suggests that it may function as an insertion signal. On the 
other hand, a hydropathy analysis of the P450 sequence (13, 
25, 59) reveals the presence of several other segments which, 
although  of  significantly  lesser  hydrophobicity  than  the 
amino-terminal segment, could in principle also function as 
insertion  or  halt-transfer  signals  and/or  interact with  the 
membrane bilayer. 
We have used an in vitro expression system to synthesize 
and incorporate into membranes natural and modified P450 
polypeptides in order to identify and characterize signals 
responsible for the insertion and anchoring of the natural 
protein in the ER. A cDNA containing the entire coding re- 
gion of cytochrome P450b was assembled from portions of 
two overlapping cDNA clones and a portion of a genomic 
clone that contained the entire first exon and provided a short 
5' coding segment. The reconstructed cDNA was incorpo- 
rated into the in vitro expression vector pSP64 and the result- 
ing plasmid (pSP450) was used for in vitro transcription- 
translation experiments in the presence or absence of dog 
pancreas microsomal membranes. 
The polypeptide encoded in the artificial messenger RNA 
synthesized in vitro comigrated with the authentic P450b, 
purified from rat liver microsomes, and was immunoprecipi- 
table with anti-P450 antibodies (not shown). When micro- 
somal membranes were present during translation, ~50% of 
the in  vitro synthesized product became membrane asso- 
ciated, as established by its flotation in a high-salt-containing 
sucrose step gradient in which membranes were separated 
from soluble components (Fig. 3 A, lanes d-f). On the other 
hand, a negligible proportion of the in vitro product was re- 
covered with the membranes when these were added after 
protein synthesis was terminated (Fig. 3 A, lanes g-i). The 
membrane-associated P450 remained exposed on the cyto- 
plasmic surface of the microsomes since it was completely 
digested to  low molecular mass  products  when proteases 
were added to the translation mixture (Fig. 3 A, lane m). The 
fact that digestion of the membrane-incorporated P450 pro- 
ceeded as extensively as with the nonmembrane-associated 
polypeptide (Fig.  3 A,  lane k) indicates that no significant 
stretch of contiguous amino acids is normally translocated 
into the microsomal lumen. From these experiments alone, 
however, one cannot eliminate the possibility that the P450 
polypeptide spans  the membrane several times  with only 
short segments reaching the luminal face of the microsomes. 
To  determine  whether  the  amino-terminal  segment  of 
P450 is indeed necessary for the cotranslational association 
of the product with the membranes, the behavior of a dele- 
tion variant (encoded in plasmid pSP450[s-])  from which 
amino acids residues 2-42 were deleted was examined in a 
similar experiment (Fig. 3 B). In this case, the product did 
not become associated with the membranes, even when they 
were present during translation (Fig. 3 B, lanes d-f). It can 
therefore be concluded that the amino-terminal segment of 
P450 is necessary for incorporation of the polypeptide into 
the membrane, most likely because it contains either the en- 
tire or part of the permanent signal that initiates the cotrans- 
lational insertion. Moreover, no other segment within the in- 
terior  of the  P450  polypeptide  could  by  itself  mediate 
association with the membrane when the first segment was 
deleted. 
These conclusions were supported by the results of experi- 
ments in which the same cDNAs were expressed in trans- 
fected HeLa cells using pSV2-based vectors (pSVP450 and 
pSVP450[s-]).  Immunottuorescence showed that the intact 
P450 expressed in vivo was distributed with the characteris- 
tic lacelike reticular pattern that corresponds to the ER (Fig. 
4 a), whereas the P450 lacking the amino-terminal segment 
was distributed diffusely throughout the cytoplasm (Fig. 4 b). 
P450 Sequences after the Amino-Terminal 
Segment Can Be Translocated into the ER Lumen 
When Preceded by the Cleavable Signal of  a 
Secretory Protein 
To determine whether the amino-terminal segment of P450 
is also responsible for halting the translocation of downstream 
sequences,  the  behavior of a  chimera  (pGHj-39P45044-491) 
in which the first 43 amino acids of P450 were replaced by 
a  segment of pregrowth hormone containing its 26-amino 
acid-long, cleavable insertion signal and the amino-terminal 
Monier et al.  Signals for Cytochrome P450 in the ER Membrane  461 Figure 3. The amino-terminal 43-amino acid segment of cytochrome P450 is necessary for the cotranslational insertion of the protein into 
microsomal membranes.  Full-length cytochrome P450 (A) and P450 deleted of amino acid residues 2-43 (B) were synthesized in vitro 
in the absence (-) or presence (co) of dog pancreas microsomal membranes, or the membranes were added after translation was completed 
(post).  (A) After translation,  the association of P450 with the membranes was determined by flotation analysis (lanes a-i) and its exposure 
on the microsomal surface by its sensitivity to proteases (lanes j-m). In lanes a-i total samples were analyzed directly by electrophoresis 
(T;  lanes a, d,  and g) or were first fractionated  into membrane (M;  lanes b,  e,  and h) and free (F;  lanes c, f, and i) fractions.  The 
lower intensity of the bands in lanes d-f reflects the inhibition of translation  caused by the membranes.  (B) Samples were subjected to 
flotation analysis as in A. 
Figure  4.  Immunofluorescence  patterns of transfected HeLa cells 
expressing intact P450 (a) or the deletion variant lacking residues 
2--42 (b). The lacelike reticular pattern in a is characteristic of pro- 
teins localized in the ER, whereas the diffuse cytoplasmic staining 
in b is that expected for a cytosolic protein,  Bar, 15 ttm. 
13 residues of the mature hormone was studied (Fig. 5). As 
expected, this chimeric protein became membrane associated 
and underwent cleavage of the pregrowth hormone insertion 
signal, although in Fig. 5 A, lane c, the bands corresponding 
to the intact and cleaved chimeras are not well separated. In 
contrast to the natural P450, however, the chimeric polypep- 
tides underwent translocation into the microsomal lumen. It 
was apparent, however, that in most molecules this translo- 
cation was only partial, since treatment with proteases con- 
verted the polypeptides into a doublet of two closely migrat- 
ing fragments of ~24  kD (Fig.  5 A,  lane d).  Only a  very 
small fraction of the inserted molecules (probably <5 %) was 
completely resistant to proteolysis and therefore appeared to 
be fully translocated into the microsomal lumen. Similar re- 
sistant fragments of the chimeras were not detected when the 
protease treatment was applied to the translation mixture in- 
cubated in the absence of membranes (Fig. 5 A, lane b). The 
finding that a segment of P450 that begins at residue 44 can 
be translocated across the membrane suggests that the de- 
leted amino-terminal portion of P450 is, in the natural pro- 
tein, not only responsible for initiating insertion but also for 
halting translocation of the downstream sequences.  On the 
other hand, the incomplete translocation of most of the pre- 
growth  hormone-P450  chimeric  molecules  indicates  that 
P450  sequences,  located  approximately between  residues 
150 and 250, halt translocation of the polypeptide across the 
membrane. 
To more precisely determine the location of the sequences 
that prevent complete translocation, the behavior of a series 
of similar pregrowth hormone-P450 chimeric polypeptides 
in which the P450 sequence was truncated at residues 425, 
271, 246, and  167 was studied. With these shorter polypep- 
tides, the change in electrophoretic mobility resulting from 
cleavage  of the  pregrowth  hormone  signal  sequence  was 
quite striking (Fig. 5, lanes g, k, o, and s). With the polypep- 
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is replaced by a peptide containing the cleavable insertion signal of growth hormone. A series of hybrid polypepti, se~ containing the first 
39 amino acids of pregrowth hormone linked to segments of P450 that extended from residues 44-167  (E), 246 tdes, 271 (C), 425 (B), 
and 491 (the COOH terminus; A) were synthesized in vitro in the presence or absence of membranes, as indicate(D)Lnd  the accessibility 
of each product to protease digestion was assessed. The arrows point to the positions of the intact chimeras and of tl, ~chimeras  processed 
by removal of the signal peptide. The arrowheads point to the doublets of protease-resistant fragments.  ~he 
tides extending to residues 425, 271, and 246 (Fig. 5, B-D), 
most molecules were incompletely translocated and protease 
treatment generated a doublet of protected fragments (Fig. 
5, lanes h, l, and p) of the same size as those obtained with 
the chimera that extends to the COOH-terminal end of P450 
(Fig. 5 A, lane d).  With the shortest chimeric polypeptide 
(Fig.  5  E),  the product processed for signal  removal was 
completely protected from the exogenous proteases (Fig. 5 
E, lane t). This suggests that, like a secretory protein, residues 
44-167 of  P450 can be fully translocated into the microsomal 
lumen. The fact that all the protected fragments generated by 
proteolytic treatment of the partially translocated polypep- 
tides were of the same  size demonstrates that in all cases 
translocation was  interrupted by the same segment within 
the P450 sequence. The presence of a doublet of protected 
segments most likely reflects an heterogeneity in the acces- 
sibility  to proteases  of potential tryptic and  chymotryptic 
cleavage sites  located near the cytoplasmic surface of the 
membrane.  A  further demonstration that the shortest chi- 
mera was discharged into the microsomal lumen, whereas 
the one that extends to residue 246 was incompletely translo- 
cated and remained membrane associated, was obtained by 
analysis of the alkali extractability of both products (Fig. 6). 
Like natural growth hormone (Fig. 6, lanes c-f),  the short 
polypeptide was  quantitatively  extracted  from the  micro- 
somes into a soluble fraction by incubation at pH 11.5 (Fig. 
6, lanes i-l), whereas a significant portion of  the longer poly- 
peptide remained membrane associated after alkaline treat- 
ment and was recovered with the sedim~  lble fraction (Fig. 
6,  lanes o-r).  ~nU 
Hydropathy analysis (13) of the P450~  ino acid sequence 
(20) reveals that, after the first amino-tamninal 20 residues, 
the second most hydrophobic segment vernin the P450 poly- 
peptide lies between residues 167 and 18,itlFig.  2). We there- 
fore considered the possibility that this 15 (:ion of the protein 
was responsible for the incomplete tranre~ation of the pre- 
growth hormone-P450 chimeras and st~slced the behavior of 
two additional chimeric variants: one (]ldiH1-39P450al166-2031) 
in  which  residues  166-203  were  renpGed  and  a  second 
(pGHt-39P450203-agt) in  which  the  groaoxa hormone-inser- 
tion signal was linked directly to the c~tboxy-terminal 288 
residues of P450. With these construcL,  adgnal cleavage was 
also apparent (Fig. 7, c and e; h and j) bui, in contrast to the 
behavior of the chimeric polypeptides containing the interior 
hydrophobic domain, the products processed for signal cleav- 
age were completely resistant to protease digestion. These 
findings suggest that no other segment downstream of resi- 
due 203 was capable of halting the translocation initiated by 
the cleavable growth hormone signal. It is worth noting that 
both of these apparently completely translocated polypep- 
tides contain a potential N-glycosylation site, which is pres- 
ent at residue 456 of the P450 sequence. However, glycosyl- 
ation did not take place,  as  indicated by the fact that the 
electrophoretic mobilities of the products were unaffected by 
digestion with endoglycosidase H  (Fig. 7, lanes d  and i). 
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cytochrome  P450  can  be  com- 
pletely translocated into the mi- 
crosomal lumen  when  preceded 
by the growth hormone signal but 
a segment between residues 167- 
246 halts translocation and serves 
as a membrane-anchoring  domain. 
Pregrowth  hormone  (lanes  a-f) 
and  the  two  shortest  pregrowth 
hormone-P450  chimeras  de- 
scribed in Fig. 5 (lanes g-r) were 
synthesized in the presence of mi- 
crosomal membranes.  Their ex- 
posure on the microsomal surface 
and integration into the membranes 
were assessed by protease diges- 
tion and resistance to alkaline ex- 
traction, respectively. S and P, su- 
pernatant  and  pellet  fractions 
obtained after alkaline treatment, 
respectively. The supernatant frac- 
tion contains the microsomal lu- 
minal  content  and  polypeptides 
not incorporated into microsomes. 
The arrows on the side of the au- 
toradiograms point to the primary 
translation products (upper) and 
to the products which underwent cleavage of the insertion signals (lower). In the schemes at the bottom of the figure, the arrows point 
to the ends of the segments contributed by different polypeptides. The arrowheads point to the cleavage site in the chimeric proteins. 
Figure 7.  Cytochrome P450  contains only one interior potential 
halt-transfer signal,  which  is  included  in  the  segment between 
residues 166 and 203. The amino-terminal segment of rat pregrowth 
hormone (first 39 residues) was used to mediate the incorporation 
into membranes of two chimeric polypeptides containing different 
portions of P450.  In one  (pGHt-39P450203 491, lanes a-e), the P450 
segment extended from residue 203 to the COOH terminus at resi- 
due 491.  In the other (pGnl-39P450a066-203); lanes f-j), the P450 
Direct Demonstration That the Amino-Terminal 
Segment of  P450 Displays Combined Insertion 
and Halt-Transfer Activities 
The  previous  experiments  demonstrated  that  the  first  43 
residues of P450 contain elements required for insertion of 
the polypeptide into membranes as well as for halting trans- 
location of downstream segments. To determine whether the 
43-amino acid segment is sufficient to effect both processes, 
we examined the behavior of a  chimera (P4501-48pGH3s_2m6) 
in which the first 48  residues of P450  replaced a  segment 
comprising the  first 37  amino acids of the pregrowth hor- 
mone sequence, which includes the cleavable insertion sig- 
nal (26 amino acids long) and the first 11 residues of the ma- 
ture hormone.  The behavior of this chimera was essentially 
identical to  that of the  natural  P450:  the polypeptide was 
efficiently integrated  into  the  membranes,  as  revealed by 
flotation analysis (Fig.  8  A,  lanes d-f),  but  remained ex- 
posed on the outer surface of the microsomes and was com- 
pletely digested by the added proteases (Fig.  8  A, lanes c' 
and d'). 
segment extended from residue 44 to the COOH terminus, but the 
portion between residues 166-203 was deleted. The translocation 
of the polypeptides into microsomes was assessed by their resis- 
tance to protease digestion, and the presence of carbohydrate by the 
effect of endoglycosidase H treatment on the electrophoretic mobil- 
ity of the product synthesized in the presence of membranes, as 
indicated. Arrows on the sides of the autoradiograms point to the 
positions of the primary translation products (upper) or of the prod- 
ucts which underwent signal cleavage (lower). The arrowheads in 
the schematic diagrams at the bottom of the figure point to the cleav- 
age site for the signal peptidase within the pregrowth hormone seg- 
ment in each polypeptide. 
The Journal of Cell Biology,  Volume 107, 1988  464 Figure & (A) An amino-terminal segment containing the first 48 residues of P450 mediates insertion of growth hormone into microsomal 
membranes but blocks its translocation into the microsomal lumen. The hybrid polypeptide P450~_4~pGH3s_:~6  (represented schematically 
at the bottom of the figure) containing the first 48 residues of P450 linked to a portion of  pregrowth hormone that lacks the cleavable insertion 
signal, as well as the following 11 amino acid residues, was synthesized in the presence of dog pancreas microsomes. The association 
of the translation products with the membranes and their exposure on the surface of the microsomes was assessed by flotation and protease 
sensitivity, respectively, as in Fig. 3. The protease sensitivity of the hybrid polypeptide is in marked contrast to the resistance of the translo- 
cated growth hormone, shown in Fig. 6. (B) The first 20 amino acids are sufficient  to effect  the combined insertion and halt-transfer functions 
of the terminal segment of P450. The insertion into membranes of P450j-20pGH39-216  was studied as in A. 
A similar experiment with a  P450-growth hormone chi- 
mera  (p4501-20pGI-I39-216) that  contains  only  the  first  20 
residues of P450 gave identical results (Fig. 8 B), indicating 
that the combined insertion and halt-transfer signal activities 
of the amino-terminal portion of P450 are in fact wholly con- 
tained within this smaller segment, which includes a stretch 
of 16 contiguous hydrophobic amino acids (Fig.  2). 
Disposition of  the Amino-Terminal Portion 
of  P450 with Respect to the ER Membrane 
It has been suggested 08,  27, 53,  58) that during the early 
stages of cotranslational insertion amino-terminal signal se- 
quences adopt a  loop configuration with the residues that 
precede the hydrophobic core of the signal remaining on the 
cytoplasmic surface of the ER membrane. If the hydrophobic 
segment in P450 achieved this configuration, traversing the 
membrane  in  an  NI-[2 (cytoplasmic) to  COOH  (luminal) 
direction, then introduction of a  signal peptidase cleavage 
site immediately after the hydrophobic stretch might be ex- 
pected to result in signal removal and elimination of the halt- 
transfer activity.  This possibility  was  examined using  the 
plasmid pSP4501-E0pGH21_2t6, which encodes a polypeptide 
in which the first 20 amino acids of pregrowth hormone are 
replaced by the corresponding residues of P450. In this hy- 
brid, the P450 signal is followed by the last six residues of 
the pregrowth hormone signal, which provides the cleavage 
site, and by the complete growth hormone sequence. In this 
case, in contrast to the situation with pSP450~_20pGH39_2~6, 
cleavage of  the P450 signal took place in a significant fraction 
of the molecules (Fig. 9, compare lane a' to lanes a and b'). 
When cleavage took place, translocation of growth hormone 
ensued,  as  shown both by the resistance of the processed 
polypeptide to digestion by exogenous proteases (Fig. 9, lane 
c') and by its extraction from the membrane by alkali treat- 
ment (Fig.  9,  lanes a-c).  The removal of the P450 signal 
demonstrates that, at some point during insertion, the resi- 
dues immediately after the signal reach the luminal side of 
the ER membrane, as predicted by the loop model. More- 
over, it suggests that signal  removal after insertion is  suf- 
ficient to ensure translocation of downstream sequences. It 
should be noted,  however,  that  some of the molecules in 
which cleavage did  not take place became membrane as- 
sociated, as indicated by their resistance to alkali extraction 
(Fig. 9, lane b), but these molecules clearly were not translo- 
cated since they were digested by the exogenous proteases 
(Fig. 9, lane c'). 
To determine whether the extreme amino terminus of P450 
remains exposed on the cytoplasmic surface of the mem- 
brane, we analyzed the behavior of a chimeric polypeptide 
in which P450 was preceded by a 34-amino acid segment de- 
rived from the amino-terminal region of  bovine opsin, which 
includes two potential glycosylation sites (23, 41). In the opsin 
molecule this segment is normally glycosylated, which indi- 
cates that it is translocated into the ER lumen, even though 
it precedes the  (noncleavable) first opsin  insertion  signal 
(19).  When  OPS]-34P450]-491  was  synthesized in  the pres- 
ence of membranes,  a  substantial  fraction of the  product 
(Fig.  10,  lane d) was glycosylated and therefore of higher 
Mr than the primary translation product (Fig.  10,  lane a). 
The  presence  of  carbohydrate  in  those  molecules  was 
demonstrated by the fact that treatment with endoglycosidase 
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P450 is partially obliterated when this segment is followed by the 
last six amino acids of the cleavable insertion  signal of pregrowth 
hormone  and the  rest of this polypeptide.  The P450t-20pGH2~-216 
polypeptide (represented schematically at the bottom of the figure) 
was synthesized in the absence (a') or presence (a-c, b', c') of dog 
pancreas microsomal membranes. Samples were analyzed directly 
(T, lane a; and lanes a' and b') or after extraction with alkali (b and 
c), which generated supernatant (S) and pellet (P) fractions.  The 
sensitivity to proteases of products  synthesized in the presence of 
membranes was also assessed (compare lanes b' and c'). The arrows 
on sides of  the autoradiogram point to the primary translation prod- 
uct  (upper)  and  to the  processed  product  that  underwent  signal 
cleavage (lower). 
H  increased their electrophoretic mobility (Fig.  10, lane e) 
to that of the polypeptide synthesized in the absence of mem- 
branes (Fig.  10, lane a). This experiment demonstrates that 
the opsin segment added to the amino terminus of the P450 
was translocated into the ER lumen, which implies that the 
,amino terminus of P450 did not remain on the cytoplasmic 
surface of the  microsomal vesicles.  Although  most of the 
glycosylated molecules behaved as  P450  and therefore re- 
mained  largely exposed on the  cytoplasmic surface of the 
membranes where they  were accessible to the  added pro- 
teases (Fig.  10, lane f); a small (but variable) fraction of the 
glycosylated molecules appeared to be protease resistant and 
therefore to have been completely translocated to the micro- 
somal lumen. This suggests that the addition of the amino- 
terminal  portion  of opsin  reduces  the  effectiveness of the 
halt-transfer signal at the amino terminus of the P450 moiety. 
Discussion 
The  results  presented  in  this  paper show  that  the  amino- 
terminal  segment  of  P450  behaves  as  a  combined  inser- 
tion-halt-transfer signal, in that it initiates incorporation of 
the nascent polypeptide into the ER membrane but does not 
Figure 10. The amino-terminal segment of opsin is translocated into 
the microsomal lumen when it is linked to the amino terminus of 
P450. The hybrid polypeptide OPSI_34P4501_491 (represented sche- 
matically at the bottom of  the figure) was synthesized in the absence 
(lanes a-c) or presence (lanes d-f) of microsomal membranes. Ali- 
quots of the reaction mixtures were either analyzed directly (a and 
d) or after treatment  with either  endoglycosidase H (lanes b and 
e) or with proteases  (lanes c and f). 
lead to translocation of the following sequences across the 
membrane. The fact that this segment is required for inser- 
tion was demonstrated by in vivo and in vitro experiments 
in which it was found that a deletion variant of P450,  from 
which residues 2-43 were removed, failed to be incorporated 
into the membranes. This showed that no other segment of 
P450 could,  independently,  initiate the insertion process. 
It  was  also  necessary  to  demonstrate  that  the  amino- 
terminal segment was responsible for the halt-transfer signal 
activity since, theoretically, the normal exposure of the bulk 
of the P450 molecule on the cytoplasmic face of the ER mem- 
brane could be due to intrinsic  features of the polypeptide 
that prevent it from traversing the membrane but do not re- 
side in the amino-terminal signal segment itself. We showed, 
however, that the portion of P450 that follows residue 43 and 
extends up to residue  167  could be efficiently translocated 
across the membrane when it was preceded by the conven- 
tional cleavable signal of the secretory protein growth hor- 
mone. This indicates that the portion that follows the signal 
does not contain any intrinsic structural barrier to transloca- 
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segment of P450 to effect both insertion and halt-transfer 
functions was demonstrated directly when this segment was 
used to mediate the insertion of the growth hormone poly- 
peptide into the ER. In this case, growth hormone became 
an intrinsic membrane protein that remained exposed on the 
cytoplasmic surface of the microsomes. The same result was 
obtained when only the first 20 residues of P450 were linked 
to growth hormone and this allowed us to conclude that both 
the insertion and halt-transfer functions are wholly contained 
in that portion of the P450 molecule. 
It should be noted that the P450 sequence (arg-gly-his-pro- 
lys-ser-arg-gly .....  ) (Fig. 2) that immediately follows the 
last hydrophobic residue at position 20 includes several posi- 
tively charged amino acids which, in principle, could have 
contributed to the halt-transfer activity (53). In fact, in the 
Pa501-20pGa39-216 chimera the P450 hydrophobic sequence 
was also followed by a sequence (ala-val-leu-arg-ala-gln-his- 
leu-his-gln-leu-ala-ala .....  )  (Fig.  2) that contains posi- 
tive charges.  However, the behavior of two other chimeras 
allows us to discard the possibility that such charges con- 
tributed  to  the  halt-transfer  activity.  Thus,  a  significant 
proportion of the P450~-2opGH2~_2~6 molecules, which con- 
tain the growth hormone insertion signal cleavage site, al- 
though incorporated into the membranes,  did not undergo 
cleavage and remained exposed on the cytoplasmic surface 
(Fig. 9). In this chimera, the sequence (pro-gln-glu-ala-gly- 
ala-leu-pro-ala-met) (Fig. 2) after the P450 hydrophobic seg- 
ment was not highly charged and yet, in the uncleaved poly- 
peptides, the amino-terminal segment served as an effective 
halt-transfer signal.  Similarly, a P450 variant (P450~_20CS- 
P45044-167), in which the hydrophobic segment was followed 
by  a  sequence  (asp-ala-gly-ala-leu-ser-arg-val-asp-leu-gln- 
leu-asp-arg-gly-gly-leu-leu-asp-ser ......  )  (Fig.  2)  with 
no net positive charge, was also inserted into the membrane 
but was not translocated (results not shown). 
The observation that the charged residues that follow the 
amino-terminal hydrophobic segment of P450 are not essen- 
tial for the halt-transfer and membrane-anchoring activities 
is  consistent with  the  finding  (11, 12,  67) that,  in  simple 
transmembrane proteins, the charged residues that follow the 
halt-transfer  signals  can  be  deleted  without  affecting the 
transmembrane disposition of the polypeptides. 
Recently,  Sakaguchi  et  al.  (55)  have  reported  that  an 
amino-terminal segment of a different form of microsomal 
P450, which is induced in rabbit liver by polycyclic hydrocar- 
bons, also leads to insertion into the ER membrane of linked 
portions of  other polypeptides, such as interleukin-2 and yeast 
mitochondrial porin, but prevents their translocation into the 
ER lumen. Moreover, in this work it was demonstrated that 
positively  charged  residues  that  follow  the  hydrophobic 
amino-terminal signal could be deleted without altering the 
capacity of the signal to effect the halt in translocation. 
It is worth noting that the capacity of the amino-terminal 
segment of the rat liver phenobarbital-inducible P450 stud- 
ied here to act as a halt-transfer signal was also manifested 
when this segment was placed within a translocatable poly- 
peptide, downstream from a cleavable insertion signal (18). 
In that case, the first 167 amino acid residues of P450 were 
linked to a truncated influenza virus hemagglutinin, replac- 
ing its transmembrane and cytoplasmic domains. The hybrid 
protein became anchored in the membrane, with its amino- 
terminal  hemagglutinin portion sequestered in  the micro- 
somal lumen and the bulk of the P450 component exposed 
on the cytoplasmic surface. On the other hand, in a similar 
experiment (18), a typical cleavable insertion signal, that of 
the hemagglutinin itself, when relocated to an internal posi- 
tion, failed to halt translocation and traversed the membrane 
without undergoing cleavage. The incapacity of this signal to 
halt translocation most likely reflects the fact that, like most 
conventional insertion signals, it contains a hydrophobic seg- 
ment shorter than the regular halt-transfer signals that serve 
as transmembrane domains. 
The halt-transfer function of the membrane-anchoring do- 
main  of cytochrome P450  distinguishes  it  from  the  first 
membrane-anchoring domain found in proteins such as Band 
III, which have cytoplasmically exposed amino termini (type 
II proteins). We have originally proposed (53) that the trans- 
membrane disposition of the latter type of proteins is ex- 
plained by the action of an interior noncleavable insertion 
signal that enters the membrane in a loop configuration, leav- 
ing its amino-terminal portion on the cytoplasmic surface, 
and mediates translocation of downstream sequences but re- 
mains anchored in the membrane after translocation is com- 
pleted. Substantial evidence has accumulated supporting this 
proposal from studies on the sequence of primary translation 
products of various type II proteins, such as the influenza 
neuraminidase (6,  17), the transferrin receptor (56), the su- 
crase isomaltase of  the intestinal brush border (26), the hepa- 
tocyte asialoglycoprotein receptor (57), and the anion chan- 
nel (Band III) (29) and glucose transporter (38) of the red 
blood cell membrane. In some cases, direct evidence for the 
translocating capacity of membrane-anchoring domains in 
type II proteins has been obtained from experiments using 
polypeptides  encoded  in  genetically engineered  chimeric 
genes (9). 
There is a class of transmembrane glycoproteins, however, 
which includes rhodopsin (19) and the 13-adrenergic receptor 
(14),  which contain no cleavable signals but have luminally 
located, glycosylated, amino-terminal domains. In such pro- 
teins, the first transmembrane domain spans the membrane 
in  the  NH2  (luminal)  to  COOH  (cytoplasmic)  direction, 
characteristic of halt-transfer signals. In contrast to the situa- 
tion with type II proteins, this disposition cannot be a direct 
consequence of the completion of an insertion process which 
was initiated by a signal that entered the membrane as a loop 
and remained in that configuration. 
Our experiments with P450 provide support for the notion 
that  the  amino-terminal  portion  of this  polypeptide first 
enters the membrane as a loop (Fig.  11 A, a) but later re- 
orients so that its amino terminus is transferred to the luminal 
surface (Fig.  11 A, b). Thus, when the normal cleavage site 
for pregrowth hormone was placed after the combined in- 
sertion-halt-transfer  signal  of P450  (in  P4501-20GH2j-2t6), 
cleavage of the signal occurred in a significant proportion of 
the molecules which were inserted in the membrane, and 
these molecules were translocated into the microsomal lu- 
men. This indicated that the cleavage site reaches the luminal 
side of the membrane (Fig. 11 B) where the signal peptidase 
is known to be located (16, 28).  Because the presence of a 
cleavage site after the hydrophobic segment is not likely to 
alter the configuration of the signal as it enters the mem- 
brane, these experiments support the notion that the natural 
P-450 signal enters as a loop (Fig.  11 A) rather than directly 
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Figure 11. Proposed reorientation of the combined insertion-halt- 
transfer signal in natural P450 and in the opsin-P450  chimera.  (A 
and B) Initially, the hydrophobic amino-terminal segment ( ~  ) of 
the nascent P450 molecule would traverse the membrane with its 
amino-terminus  remaining exposed in the cytoplasm (A, a). The 
amino acid residues immediately following the hydrophobic stretch 
would reach the lumen of the ER and cleavage by the signal pepti- 
dase would take place, were a cleavage site located at that position, 
as in P450]-20pGH21-216 (B, a). When cleavage takes place,  trans- 
location is not halted and the later portion  of the polypeptide  is 
sequestered  in the lumen of the ER (B, b). When cleavage does 
not take place, as in the native P450 or a fraction of the P450t_20- 
pGH21-216 molecules, the signal reorients within the membrane so 
that  its amino terminus  is transferred  to the  luminal  face of the 
membrane and the segment that follows the signal is ejected into 
the cytoplasm (A, b). For simplicity, the ribosome in which the na- 
scent chain is contained has been omitted from the schemes. (C) 
The cotranslational  insertion  into the  ER membrane  of OPSl_34- 
P450t-49t is depicted.  In this protein,  the amino terminus of P450 
has been extended to include the 34 amino-terminal  amino  acid 
residues of opsin, which include two glycosylation sites and in the 
native opsin are translocated across the ER membrane.  When the 
P450 signal enters the membrane as part of a loop, the preceding 
opsin portion is initially located on the cytoplasmic surface of the 
membrane (a). It is proposed that soon thereafter, the P450 signal 
reorients within the membrane and, as a result, the opsin segment 
is translocated to the ER lumen, where it is glycosylated (b). This 
reorientation  brings  about the disappearance  of the  loop,  which 
causes the halt in translocation that is responsible for the predomi- 
nant exposure of P450 on the cytoplasmic side of the membrane. 
in  the  NH2  (luminal)  to  COOH  (cytoplasmic) orientation 
(shown in Fig.  ll A, b). Evidence for a reorientation of the 
signal  that  destroys  the  initial  loop  was  provided  by the 
finding  that  when  the  chimera OPS1-34P4501-491 (in  which 
the amino-terminal segment of opsin that precedes the first 
signal in that protein was linked to the amino terminus of the 
intact P450) was synthesized in the presence of membranes, 
the opsin component was glycosylated and hence was trans- 
located to the lumen of the microsomes (Fig.  11  C).  This 
leads us to propose that the reorientation of the insertion sig- 
nal in P450 which causes the disappearance of the intramem- 
brane loop is responsible for the halt in translocation.  Such 
a reorientation would take place soon after insertion begins 
since, although a large proportion of the chimeric molecules 
(P4501-20GH21-216) that contained a cleavage site immediately 
after the P450 signal underwent cleavage, a comparable frac- 
tion did not undergo cleavage but became inserted and re- 
mained anchored in the membranes, with the growth hor- 
mone component exposed on the cytoplasmic surface of the 
microsomes. In these molecules, halt-transfer (and presum- 
ably reorientation of the signal) must have taken place before 
cleavage could occur. The fact that in the mature P450 the 
membrane-anchoring domain exists in the NH2 (luminal) to 
COOH (cytoplasmic) configuration expected from a reorien- 
tation is apparent from the finding that the portion of the 
polypeptide that immediately follows the hydrophobic seg- 
ment (between residues 29 and 38) has been shown to be ac- 
cessible to site-specific antibodies applied to the cytoplasmic 
surface (13).  If the capacity of the combined insertion-halt- 
transfer signal to reorient soon after entering the membrane 
as a loop is essential to effect the halt in translocation, then 
it  seems  possible  that  the  insertion-membrane-anchoring 
domains of type II proteins do not effect halt-transfer simply 
because they are incapable of reorienting. This could possi- 
bly  be  due  to  restrictions  imposed  by  the  properties  of 
preceding polypeptide sequences,  which would have to be 
translocated across the membrane, as well as succeeding se- 
quences,  which  would  have  to  be  ejected  back  into  the 
cytoplasm (Fig.  11, A and C). 
The  behavior  of the  amino-terminal  segment  of P450 
strongly resembles that of the first transmembrane domain 
in  opsin,  whose  combined  insertion-halt-transfer  signal 
function  was  demonstrated  (2,  19)  by the  analysis of the 
translocation  capacity  and  transmembrane  disposition  of 
truncated and interior deletion variants. This work also led 
to the recognition that segments of opsin that normally serve 
as  interior  insertion  signals  can  undergo  a  reorientation 
when engineered to become the sole signals in polypeptides 
in which they are preceded by the amino-terminal segment 
of opsin (2). 
It has recently  been observed that  simple interior  halt- 
transfer signals,  such as those in the ~t heavy chain of the 
membrane form of IgM  (37)  or the  Semliki Forest Virus 
envelope glycoprotein (66),  which  normally have an NH2 
(luminal)  to COOH  (cytoplasmic) orientation,  when  relo- 
cated at or near the amino terminus of a nascent polypeptide 
can function as effective insertion signals that facilitate trans- 
location  of later  portions  of the  polypeptide  and  remain 
membrane anchored but do not halt transfer. The behavior 
of these  relocated  signals  and  their  final  transmembrane 
orientation contrasts with that of the natural amino-terminal 
sequence in P450, which demonstrates that the behavior of 
the latter is not simply due to its amino-terminal location. 
Rather,  the P450  signal must contain specific features,  al- 
most certainly in the regions flanking the hydrophobic do- 
main, that, after it initiates insertion, allow it to reorient and 
halt translocation. 
The analysis of the membrane insertion of a series of chi- 
meric proteins (pGH1-39P45044-491, pGHl_39P4504¢-167, pGHI_39- 
P45044-246,  pGHI-39P45044-271,  and  pGH1-39P45044~91),  in 
which the cleavable insertion signal of growth hormone re- 
placed the amino-terminal portion of P450 indicated that, in 
addition  to  the  amino-terminal  combined  insertion-halt- 
transfer signal, an interior segment of the P450 polypeptide, 
located  approximately between  residues  150  and  250,  is 
capable,  with  high but not complete efficiency, of halting 
translocation across the membrane. This segment was lo- 
cated more precisely by the analysis of the insertion of pre- 
growth hormone-P450 chimeras with additional deletions in 
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hormone insertion signal was linked directly to a P450 seg- 
ment extending from  residues  203  to 491,  and in another 
(pGHi-39P450166_203) it was linked to a P450 portion that ex- 
tended from residues 44  to 491,  but from which residues 
165-204 were deleted. With both of these chimeras, translo- 
cation was complete.  This defined more precisely the posi- 
tion of the segment capable of mediating halt-transfer and 
demonstrated that no other portion within the molecule had 
similar properties. 
An examination of the P450 sequence (Fig. 2) shows that 
the interior segment capable  of arresting  translocation in- 
cludes the second most highly hydrophobic segment within 
the molecule,  which  is  located between  residues  167  and 
185. With an average hydropathy of 1.75 (calculated using the 
values of Kyte and Doolittle [32]), this sequence is consider- 
ably  less  hydrophobic than most  well-characterized  mem- 
brane-anchoring domains, such as the halt-transfer  signals in 
type I membrane proteins or the insertion-signal membrane- 
anchoring domains of type II proteins. 
The  capacity  of the  interior  segment  of P450  to  arrest 
translocation in the chimeric  proteins raises the possibility 
that in the natural protein it also contributes to anchoring the 
polypeptide to the membrane. It should be recalled that when 
the amino-terminal 43 residues were deleted,  P450 did not 
associate with the membranes,  which clearly demonstrated 
that the interior segment cannot by itself initiate insertion. 
On the other hand, it is conceivable that when the protein is 
anchored  in  the  membrane  by  the  amino-terminal  inser- 
tion-halt-transfer signal,  the interior segment can become 
membrane associated.  This could happen cotranslationally, 
in a process which could involve the signal recognition parti- 
cle  (see  reference  62),  or posttranslationally,  in a  process 
analogous to that which leads to the incorporation in the ER 
of proteins such as cytochrome b5 and its reductase (8, 44, 
47),  which are  synthesized in  free  polysomes  and are  in- 
serted  in the membrane through their COOH-terminal do- 
mains.  Although in  a  study  using  site-specific  antibodies 
raised against synthetic peptides corresponding to different 
portions of the P450 segment (13) it was not possible to deter- 
mine whether the segment between residues  168 and 185 is 
exposed on the microsomal  surface or is buried within the 
membrane,  it was shown that preceding (residues  122-131) 
and later (residues  186-193) peptide segments are exposed 
on the cytoplasmic surface of the ER.  This indicates that if 
the segment encompassing residues  168-185 contributes to 
the anchoring of the protein in the membrane,  it must only 
form a shallow loop within the membrane since its length is 
insufficient for it to traverse  the phospholipid bilayer twice. 
It is of course also possible that the interior segment is not 
associated  with the membrane  and that its hydrophobicity 
simply reflects its capacity to interact with other hydrophobic 
portions of the molecule or perhaps with hydrophobic sub- 
strates  that are bound to P450. 
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